Leaflet REPAGLINIDA LABORMED 0.5mg film-coated tablets
Indicated for: type 2 diabetes mellitus
Route of administration: oral
Substance: repaglinide (antidiabetic)
ATC: A10BX02 (Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Other blood glucose lowering drugs, excl. insulins)
This medicine may lower blood sugar.
Repaglinide is a medication used to control blood sugar levels in patients with type 2 diabetes. It stimulates the pancreas to release insulin, thereby helping to lower blood sugar levels after meals.
The medication is taken orally, usually before meals, and should be used as directed by your doctor. It is important to follow the recommended diet and exercise regimen to achieve the best results.
Side effects may include hypoglycemia (low blood sugar), nausea, diarrhea, or weight gain. In rare cases, severe allergic reactions or other complications may occur, requiring immediate medical attention.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as liver or kidney diseases, to ensure the safe use of repaglinide.
General data about REPAGLINIDA LABORMED 0.5mg
- Substance: repaglinide
- Date of latest medicines list: 01-01-2014
- Product code: W60095001
- Concentration: 0.5mg
- Pharmaceutical form: film-coated tablets
- Quantity: 30
- Product type: Generic medicine
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for repaglinide
Concentrations available for repaglinide
- 0.5mg
- 1mg
- 2mg
- 4mg